Literature DB >> 25223997

New insights into the in vitro susceptibility of Pythium insidiosum.

Erico S Loreto1, Juliana S M Tondolo1, Maiara B Pilotto1, Sydney H Alves2, Janio M Santurio3.   

Abstract

We have determined the in vitro activity of several antibacterial and antifungal drugs against Pythium insidiosum using broth microdilution (BMD), disk diffusion, and Etest methods. The largest zones of inhibition (disk diffusion) and the lowest BMD and Etest MICs were observed for azithromycin, clarithromycin, linezolid, mupirocin, doxycycline, minocycline, and tigecycline. The in vitro activities observed suggest that antibacterials, which act by inhibiting protein synthesis, are promising candidate therapies for the treatment of pythiosis.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25223997      PMCID： PMC4249561          DOI： 10.1128/AAC.02680-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

2.  Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child.

Authors:  J L Shenep; B K English; L Kaufman; T A Pearson; J W Thompson; R A Kaufman; G Frisch; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

4.  Clinical and epidemiological analyses of human pythiosis in Thailand.

Authors:  Theerapong Krajaejun; Boonmee Sathapatayavongs; Roongnapa Pracharktam; Prawat Nitiyanant; Paisan Leelachaikul; Wanchai Wanachiwanawin; Angkana Chaiprasert; Paraya Assanasen; Marisa Saipetch; Piroon Mootsikapun; Ploenchan Chetchotisakd; Arnuparp Lekhakula; Winyou Mitarnun; Sineenart Kalnauwakul; Khuanchai Supparatpinyo; Romanee Chaiwarith; Siri Chiewchanvit; Napaporn Tananuvat; Sawet Srisiri; Chusana Suankratay; Wanla Kulwichit; Mawin Wongsaisuwan; Shawarash Somkaew
Journal:  Clin Infect Dis       Date:  2006-07-13       Impact factor: 9.079

5.  Pythium insidiosum keratitis.

Authors:  D Murdoch; D Parr
Journal:  Aust N Z J Ophthalmol       Date:  1997-05

6.  Pythium insidiosum pleuropericarditis complicating pneumonia in a child with leukemia.

Authors:  John A Heath; Timothy E Kiehn; Arthur E Brown; Michael P LaQuaglia; Laurel J Steinherz; Gonzalo Bearman; May Wong; Peter G Steinherz
Journal:  Clin Infect Dis       Date:  2002-08-23       Impact factor: 9.079

7.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

8.  Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals.

Authors:  Daniela Isabel Brayer Pereira; Janio Morais Santurio; Sydney Hartz Alves; Juliana Siqueira Argenta; Luciana Pötter; Andréia Spanamberg; Laerte Ferreiro
Journal:  J Antimicrob Chemother       Date:  2007-09-03       Impact factor: 5.790

Review 9.  Orbital pythiosis: a non-fungal disease mimicking orbital mycotic infections, with a retrospective review of the literature.

Authors:  L Mendoza; S H Prasla; L Ajello
Journal:  Mycoses       Date:  2004-02       Impact factor: 4.377

Review 10.  Human pythiosis associated with thalassemia hemoglobinopathy syndrome.

Authors:  B Sathapatayavongs; P Leelachaikul; R Prachaktam; V Atichartakarn; S Sriphojanart; P Trairatvorakul; S Jirasiritham; S Nontasut; C Eurvilaichit; T Flegel
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226
View more
  16 in total

1.  In Vitro Activities of Miltefosine and Antibacterial Agents from the Macrolide, Oxazolidinone, and Pleuromutilin Classes against Pythium insidiosum and Pythium aphanidermatum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Daniele C Oliveira; Janio M Santurio; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents.

Authors:  Navaporn Worasilchai; Ariya Chindamporn; Rongpong Plongla; Pattama Torvorapanit; Kasama Manothummetha; Nipat Chuleerarux; Nitipong Permpalung
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Evolution of the Sterol Biosynthetic Pathway of Pythium insidiosum and Related Oomycetes Contributes to Antifungal Drug Resistance.

Authors:  Tassanee Lerksuthirat; Areeporn Sangcakul; Tassanee Lohnoo; Wanta Yingyong; Thidarat Rujirawat; Theerapong Krajaejun
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Pythium insidiosum Keratitis: Past, Present, and Future.

Authors:  Bharat Gurnani; Kirandeep Kaur; Shweta Agarwal; Vaitheeswaran G Lalgudi; Nakul S Shekhawat; Anitha Venugopal; Koushik Tripathy; Bhaskar Srinivasan; Geetha Iyer; Joseph Gubert
Journal:  Ophthalmol Ther       Date:  2022-07-05

Review 5.  A Review: Antimicrobial Therapy for Human Pythiosis.

Authors:  Sadeep Medhasi; Ariya Chindamporn; Navaporn Worasilchai
Journal:  Antibiotics (Basel)       Date:  2022-03-26

6.  In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum.

Authors:  Francielli P K Jesus; Érico S Loreto; Laerte Ferreiro; Sydney H Alves; David Driemeier; Suyene O Souza; Raqueli T França; Sonia T A Lopes; Maiara B Pilotto; Aline Ludwig; Maria I Azevedo; Tatiana C Ribeiro; Juliana S M Tondolo; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

7.  Efficacy of Azithromycin and Miltefosine in Experimental Systemic Pythiosis in Immunosuppressed Mice.

Authors:  Erico S Loreto; Juliana S M Tondolo; Francielli P K de Jesus; Camila M Verdi; Carla Weiblen; Maria I de Azevedo; Glaucia D Kommers; Janio M Santurio; Régis A Zanette; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

8.  In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum.

Authors:  Sabrina R Itaqui; Camila M Verdi; Juliana S M Tondolo; Thaisa S da Luz; Sydney H Alves; Janio M Santurio; Érico S Loreto
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Evaluating the efficacy of surgical excision and topical dimethyl sulphoxide (DMSO) in the treatment of equine cutaneous pythiosis.

Authors:  A Atiba; A Ghazy; M H Hamad
Journal:  Iran J Vet Res       Date:  2020       Impact factor: 1.376

Review 10.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.